Nice Insight Reports
Biotech Funding Ups and Downs
April Stanley, MS MBA
Nice Insight
PAO-04-24-NI-01Apr 02, 2024
Alloy Therapeutics and Wheeler Bio Announce Preferred Service Offering for Alloy Partners to Accelerate the Translation from Discovery to CMC
Wheeler Bio
PR-M11-23-01Nov 08, 2023
Wheeler Bio Announces Grand Opening of Biomanufacturing Facility
Wheeler Bio
PR-M10-23-01Oct 05, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01Jan 04, 2023
Synthetic Biology
Synthetic Biology: A Potential Game-Changer for the Biopharma Industry
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-12-022-NI-01Dec 23, 2022
Digital Therapeutics
Digital Therapeutics and the Song of the Future of Healthcare
Chris E. Rivera; Xavier A. Figueroa
EMulate Therapeutics
PAO-12-022-CL-02Dec 20, 2022
Hemostatic
Stopping Bleeds and Saving Lives
Joe Landolina
Cresilon
PAO-11-022-CL-09Nov 16, 2022
Plant-Inspired Drug Discovery
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Andrea Small-Howard, Ph.D.
Gb Sciences, Inc.
PAO-08-022-CL-01Sep 06, 2022
Life Science Industrials
Life Science Industrials Are Key to the Growth of the Biopharma Industry
Reinhard Vogt
Dynamk Capital
PAO-07-022-CL-05Aug 04, 2022
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03Jul 12, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02Jun 24, 2022
Biotechs
10 More Biotechs Making Moves in 2022
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-07Jun 24, 2022
Enabling Drug Discovery Targeting Ion Channels
Doug Krafte, Ph.D.
Icagen
Ion ChannelsMay 19, 2022
Global License Agreement
Hovione and JIXING Announce an Exclusive Global License Agreement for Ophthalmology Program
Hovione
PR-M05-22-04May 09, 2022
Investment
Bringing Value to Pharma and Biopharma
Commercial Healthcare Partners
PAO-04-22-R250-75Apr 29, 2022
CRISPR Clinical Trial
SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001
SNIPR BIOME
PR-M04-22-11Apr 20, 2022
Artificial Intelligence
Bringing Artificial Intelligence to Biopharma
TeselaGen Biotechnology
PAO-04-22-R250-07Apr 01, 2022
Arizona Bioscience
Biotechnology Growth in Arizona
Arizona Bioindustry Association
PAO-04-22-R250-04Apr 01, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17Mar 30, 2022
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-07Mar 23, 2022